Physician

John R Velky, M.D.

According to 2025 Medicare claims, John Velky, M.D. (NPI: 1659307593) practices family practice in the Augusta-Richmond County, GA-SC market, with the plurality of this provider's patient population coming from Aiken, SC. This provider's primary affiliated billing organization is PIEDMONT MEDICAL CARE CORPORATION (NPI: 1912956046; TIN: 582092768) and primary practice location at 29841-3800. Velky is affiliated with the Piedmont Clinic ACO LLC (ACO ID: A3250), participating under the MSSP model.

Velky's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 961 traditional Medicare patients, billed 13,346 HCPCS/CPT codes, and received $249,285 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 25,110 prescription claims across 1,597 beneficiaries totaling $1,829,126 in drug costs, led by Ozempic (Semaglutide). DME data shows 361 claims. Open Payments data shows 132 records totaling $2,432. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $141,220 to $249,285. Similarly, Part D prescription costs have risen steadily, from $871,233 to $1,829,126. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $18,566 and ending at $19,426.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	843	3,463	$141,220
2016	901	4,030	$213,540
2017	1,013	4,078	$183,167
2018	986	3,963	$181,883
2019	1,030	4,228	$190,231
2020	1,024	4,604	$208,440
2021	1,031	4,180	$246,361
2022	1,033	4,351	$243,580
2023	943	3,635	$194,432
2024	961	13,346	$249,285

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	972	18,761	$871,233
2016	979	19,793	$876,212
2017	1,030	21,880	$927,024
2018	1,095	21,477	$1,128,093
2019	1,173	20,336	$1,163,205
2020	1,236	18,802	$1,146,155
2021	1,276	18,561	$1,321,801
2022	1,395	20,162	$1,560,700
2023	1,477	23,423	$2,018,657
2024	1,597	25,110	$1,829,126

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	158	716	$15,339
2016	128	537	$9,025
2017	79	502	$6,985
2018	95	513	$7,825
2019	93	441	$6,768
2020	85	396	$8,445
2021	94	421	$13,285
2022	73	360	$11,669
2023	87	325	$9,475
2024	131	361	$72,979

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	543	543	$121
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	680	1,122	$84
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	566	973	$61
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	420	623	$11
83036	Hemoglobin a1c level	226	384	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	182	7,624	$222,956
Mounjaro	Tirzepatide	146	5,546	$198,767
Eliquis	Apixaban	202	8,520	$164,131
Farxiga	Dapagliflozin Propanediol	145	7,380	$132,020
Trulicity	Dulaglutide	112	3,640	$114,122

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4353	Intermittent urinary catheter, with insertion supplies	N	28	28	$59,031
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	22	$7,320
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	41	134	$1,445
A7031	Face mask interface, replacement for full face mask, each	N	N/R	12	$1,024
A7030	Full face mask used with positive airway pressure device, each	N	N/R	12	$957

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	132	$2,432	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for John R. Velky, M.D.?

Tedicare shows public-source Medicare data for John R. Velky, M.D. (NPI 1659307593), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John R. Velky, M.D. have ACO affiliation data?

John R. Velky, M.D. is shown with ACO affiliation data for Piedmont Clinic ACO LLC (MSSP, ACO ID A3250).

What billing organization is linked to John R. Velky, M.D.?

John R. Velky, M.D. is linked to PIEDMONT MEDICAL CARE CORPORATION (billing NPI 1912956046) in the available physician profile data.

Does John R. Velky, M.D. have Open Payments data?

John R. Velky, M.D. has 132 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.